Robert Kirby, MD, Oncology, Plano, TX, Medical City Plano

RobertLewisKirbyMD

Oncology Plano, TX

Hematologic Oncology

Physician

Dr. Kirby is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kirby's full profile

Already have an account?

Education & Training

  • University of Kansas School of Medicine
    University of Kansas School of MedicineFELLOWSHIP
  • University of Kansas School of Medicine
    University of Kansas School of MedicineFELLOWSHIP
  • University of Kansas School of Medicine
    University of Kansas School of MedicineRESIDENCY
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1982 - 2021
  • KS State Medical License
    KS State Medical License 1977 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Fellow American College of Physicians
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • Adjuvant Chemotherapy with Doxorubicin and Cyclophosphamide in Women with Rapidly Proliferating Node-Negative Breast Cancer  
    Jones, S., Clark, G., Kirby, R., et al, Clinical Breast Cancer Research, Vol 3, No. 2, 2002
  • Low Proliferation Rate of Invasive Node Negative Breast cancer Predicts for a Favorable Outcome Without Adjuvant Chemotherapy. Prospective evaluation of 669 Patients.  
    Jones, S., Clark,, Kolester, S., Kirby, R., et al., Clinical Breast Cancer Research, 6/2001
  • Randomized Double-Blind Prospective Trial to Evaluate the Effects of Sargramostim Versus Placebo in a Moderate Dose Flourouricil, Doxorubicin and Cyclophosphamide Adju...  
    Jones, S.E., Schottstaedt, M.W., Duncan, LA, Kirby R.L, et al, Journal of Clinical Oncology Vol 14, No. 11, 1997
  • Join now to see all

Abstracts/Posters

  • A Randomized, Double-Blind, Placebo Controlled Trial of P1XY321 After Moderate Dose FAC in Stage II and III Breast Cancer
    Jones,S., Khandelwal, p.,McIntyre, K.,Mennel, R., Orr, D., Kirby, R., et al, Proceedings of the American Society of Clinical Oncology, Abstract, 1997

Press Mentions

  • Multidisciplinary Care Improves Outcomes of Patients with Brain Metastases
    Multidisciplinary Care Improves Outcomes of Patients with Brain MetastasesDecember 05, 2018
  • Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects Nonsmokers
    Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24, 2017
  • New Test Uncovers Metabolic Vulnerabilities in Kidney Cancer
    New Test Uncovers Metabolic Vulnerabilities in Kidney CancerAugust 29, 2018
  • Join now to see all

Committees

  • Chairman 2017-present, Institutional Review Board 2013 - Present
  • Chairman 2015, Medical Center of Plano-Board of Trustees 2011 - 2015

Professional Memberships

Hospital Affiliations